Bladder cancer
Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBC

Miriam (78 years old)

Miriam, a 78-year-old opera singer, has sung in theatres all over the world. Now she enjoys a simple life in a small cottage surrounded by vineyards.

She underwent a TURBT of a 4 cm papillary tumour at the right bladder wall, which was detected during a CT scan of the abdomen/pelvis for an ileal tumour.

Assessment summary:

  • Passive smoker until the age of 38
  • Medical history:
    • Gastric ulcers, hypertension, glaucoma
    • Left breast cancer 6 years ago: treated with surgery + radiotherapy
    • Recent ileal neuroendocrine tumour pT4 pN2 M1: treated with surgery
  • Macroscopic haematuria a few days before the first urological consultation
  • ECOG PS: 2
  • Creatinine level: 42 µmol/l
  • Maximal debulking TURBT:
    • Incomplete resection at depth
    • High-grade UCa infiltrating up to the muscularis
    • Minimal pT2
  • CT scan of thorax/abdomen/pelvis: no distant lesions or synchronous UTUC
  • TMT:
    • No residual tumour on second TURBT
    • Intensity modulated RT on the entire bladder (55 Gy in 20 fractions)
    • Chemotherapy with fluorouracil and mitomycin C

To detect non-response after TMT, which option you choose for this patient?